Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank20
3Y CAGR-8.6%
5Y CAGR-4.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-8.6%/yr
Annual compound
5Y CAGR
-4.7%/yr
Recent deceleration
Percentile
P20
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | +12.6% |
| 2024 | 0.02 | -44.8% |
| 2023 | 0.03 | +22.7% |
| 2022 | 0.03 | -48.2% |
| 2021 | 0.05 | +98.9% |
| 2020 | 0.03 | - |